90 related articles for article (PubMed ID: 17824960)
21. Molecular aspects of rheumatoid arthritis: role of transcription factors.
Okamoto H; Cujec TP; Yamanaka H; Kamatani N
FEBS J; 2008 Sep; 275(18):4463-70. PubMed ID: 18662303
[TBL] [Abstract][Full Text] [Related]
22. Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production.
Abdollahi-Roodsaz S; Joosten LA; Helsen MM; Walgreen B; van Lent PL; van den Bersselaar LA; Koenders MI; van den Berg WB
Arthritis Rheum; 2008 Dec; 58(12):3753-64. PubMed ID: 19035506
[TBL] [Abstract][Full Text] [Related]
23. Poly(ADP-ribose) polymerase inhibition reduces tumor necrosis factor-induced inflammatory response in rheumatoid synovial fibroblasts.
García S; Bodaño A; Pablos JL; Gómez-Reino JJ; Conde C
Ann Rheum Dis; 2008 May; 67(5):631-7. PubMed ID: 17890271
[TBL] [Abstract][Full Text] [Related]
24. Melanoma inhibitory activity, a biomarker related to chondrocyte anabolism, is reversibly suppressed by proinflammatory cytokines in rheumatoid arthritis.
Vandooren B; Cantaert T; van Lierop MJ; Bos E; De Rycke L; Veys EM; De Keyser F; Bresnihan B; Luyten FP; Verdonk PC; Tak PP; Boots AH; Baeten D
Ann Rheum Dis; 2009 Jun; 68(6):1044-50. PubMed ID: 18633128
[TBL] [Abstract][Full Text] [Related]
25. FLIP and MAPK play crucial roles in the MLN51-mediated hyperproliferation of fibroblast-like synoviocytes in the pathogenesis of rheumatoid arthritis.
Ha JE; Choi YE; Jang J; Yoon CH; Kim HY; Bae YS
FEBS J; 2008 Jul; 275(14):3546-55. PubMed ID: 18513326
[TBL] [Abstract][Full Text] [Related]
26. Outside-to-inside signaling through transmembrane tumor necrosis factor reverses pathologic interleukin-1beta production and deficient apoptosis of rheumatoid arthritis monocytes.
Meusch U; Rossol M; Baerwald C; Hauschildt S; Wagner U
Arthritis Rheum; 2009 Sep; 60(9):2612-21. PubMed ID: 19714631
[TBL] [Abstract][Full Text] [Related]
27. Central role of the MEK/ERK MAP kinase pathway in a mouse model of rheumatoid arthritis: potential proinflammatory mechanisms.
Thiel MJ; Schaefer CJ; Lesch ME; Mobley JL; Dudley DT; Tecle H; Barrett SD; Schrier DJ; Flory CM
Arthritis Rheum; 2007 Oct; 56(10):3347-57. PubMed ID: 17907188
[TBL] [Abstract][Full Text] [Related]
28. Role of Wnt-5A in interleukin-1beta-induced matrix metalloproteinase expression in rabbit temporomandibular joint condylar chondrocytes.
Ge X; Ma X; Meng J; Zhang C; Ma K; Zhou C
Arthritis Rheum; 2009 Sep; 60(9):2714-22. PubMed ID: 19714632
[TBL] [Abstract][Full Text] [Related]
29. Role of TL1A in the pathogenesis of rheumatoid arthritis.
Zhang J; Wang X; Fahmi H; Wojcik S; Fikes J; Yu Y; Wu J; Luo H
J Immunol; 2009 Oct; 183(8):5350-7. PubMed ID: 19786547
[TBL] [Abstract][Full Text] [Related]
30. Low level light effects on inflammatory cytokine production by rheumatoid arthritis synoviocytes.
Yamaura M; Yao M; Yaroslavsky I; Cohen R; Smotrich M; Kochevar IE
Lasers Surg Med; 2009 Apr; 41(4):282-90. PubMed ID: 19347944
[TBL] [Abstract][Full Text] [Related]
31. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
[TBL] [Abstract][Full Text] [Related]
32. [Effects of induction of tubular epithelial-myofibroblast transition by monocyte chemoattractant protein-1 and mechanism thereof: an in vitro experiment].
Li HL; Zheng FL; Zhao B
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):400-5. PubMed ID: 18581895
[TBL] [Abstract][Full Text] [Related]
33. Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis.
Hartgring SA; van Roon JA; Wenting-van Wijk M; Jacobs KM; Jahangier ZN; Willis CR; Bijlsma JW; Lafeber FP
Arthritis Rheum; 2009 Sep; 60(9):2595-605. PubMed ID: 19714586
[TBL] [Abstract][Full Text] [Related]
34. Serum amyloid A-induced IL-6 production by rheumatoid synoviocytes.
Koga T; Torigoshi T; Motokawa S; Miyashita T; Maeda Y; Nakamura M; Komori A; Aiba Y; Uemura T; Yatsuhashi H; Ishibashi H; Eguchi K; Migita K
FEBS Lett; 2008 Mar; 582(5):579-85. PubMed ID: 18243142
[TBL] [Abstract][Full Text] [Related]
35. JNK- and IkappaB-dependent pathways regulate MCP-1 but not adiponectin release from artificially hypertrophied 3T3-L1 adipocytes preloaded with palmitate in vitro.
Takahashi K; Yamaguchi S; Shimoyama T; Seki H; Miyokawa K; Katsuta H; Tanaka T; Yoshimoto K; Ohno H; Nagamatsu S; Ishida H
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E898-909. PubMed ID: 18303122
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide comparison between IL-17A- and IL-17F-induced effects in human rheumatoid arthritis synoviocytes.
Zrioual S; Ecochard R; Tournadre A; Lenief V; Cazalis MA; Miossec P
J Immunol; 2009 Mar; 182(5):3112-20. PubMed ID: 19234208
[TBL] [Abstract][Full Text] [Related]
37. The regulatory role of nerve growth factor and its receptor system in fibroblast-like synovial cells.
Raychaudhuri SP; Raychaudhuri SK
Scand J Rheumatol; 2009; 38(3):207-15. PubMed ID: 19177265
[TBL] [Abstract][Full Text] [Related]
38. Structure of human monocyte chemoattractant protein 4 (MCP-4/CCL13).
Barinka C; Prahl A; Lubkowski J
Acta Crystallogr D Biol Crystallogr; 2008 Mar; 64(Pt 3):273-8. PubMed ID: 18323622
[TBL] [Abstract][Full Text] [Related]
39. CCL13 and human diseases.
Li L; Dai F; Wang L; Sun Y; Mei L; Ran Y; Ye F
Front Immunol; 2023; 14():1176639. PubMed ID: 37153575
[TBL] [Abstract][Full Text] [Related]
40. The multiple faces of CCL13 in immunity and inflammation.
Mendez-Enriquez E; García-Zepeda EA
Inflammopharmacology; 2013 Dec; 21(6):397-406. PubMed ID: 23846739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
